[Cesarean section in a woman with acute blood-stage malaria].

Rev Esp Anestesiol Reanim

Servicio de Anestesiología y Reanimación, Hospital Universitario Maternal La Paz, Madrid.

Published: December 2007

Malaria infection during pregnancy is a serious health problem in most of the world's tropical regions. The disease has also been imported into Western countries, however, as an increasing number of infected women, who may become pregnant, emigrate from areas where malaria is endemic. Infection during pregnancy can have serious repercussions for both mother and fetus. Early diagnosis and multidisciplinary management are essential. We report the case of a woman from Guinea who debuted with severe, acute blood-stage malaria in the 32nd week of pregnancy and was admitted to the recovery care unit.

Download full-text PDF

Source

Publication Analysis

Top Keywords

acute blood-stage
8
infection pregnancy
8
pregnancy serious
8
[cesarean woman
4
woman acute
4
blood-stage malaria]
4
malaria] malaria
4
malaria infection
4
serious health
4
health problem
4

Similar Publications

Introduction: Malaria remains a significant burden, and a fully protective vaccine against is critical for reducing morbidity and mortality. Antibody responses against the blood-stage antigen Merozoite Surface Protein 2 (MSP2) are associated with protection from malaria, but its extensive polymorphism is a barrier to its development as a vaccine candidate. New tools, such as long-read sequencing and accurate protein structure modelling allow us to study the genetic diversity and immune responses towards antigens from clinical isolates with unprecedented detail.

View Article and Find Full Text PDF
Article Synopsis
  • Pro-inflammatory immune responses are suppressed during blood-stage malaria, but the specific molecular mechanisms behind this are not fully clear.
  • This study reveals that the co-inhibitory receptors TIGIT and PD-1 are increased in certain T cells during a non-lethal malaria infection.
  • Blocking both TIGIT and PD-L1 together leads to better parasite control and heightened production of key immune signaling molecules, suggesting these receptors play a crucial role in managing the body's immune response during malaria infection.
View Article and Find Full Text PDF

SARS-CoV-2 decreases malaria severity in co-infected rodent models.

Front Cell Infect Microbiol

January 2024

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.

Coronavirus disease 2019 (COVID-19) and malaria, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and parasites, respectively, share geographical distribution in regions where the latter disease is endemic, leading to the emergence of co-infections between the two pathogens. Thus far, epidemiologic studies and case reports have yielded insufficient data on the reciprocal impact of the two pathogens on either infection and related diseases. We established novel co-infection models to address this issue experimentally, employing either human angiotensin-converting enzyme 2 (hACE2)-expressing or wild-type mice, in combination with human- or mouse-infective variants of SARS-CoV-2, and the rodent malaria parasite.

View Article and Find Full Text PDF

Background: Plasmodium knowlesi is an established experimental model for basic and pre-clinical malaria vaccine research. Historically, rhesus macaques have been the most common host for malaria vaccine studies with P. knowlesi parasites.

View Article and Find Full Text PDF

Background: As per estimates by WHO in 2021 almost half of the world's population was at risk of malaria and > 0.6 million deaths were attributed to malaria. Therefore, the present study was aimed to explore the antimalarial activity of extracts derived from the leaves of the plant Anacardium occidentale L.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!